Trial Profile
A Phase 3b, Randomized, Double-Blind, Placebo-Control, Multicenter, Evaluation of the Safety and Efficacy of N1539 Administered Preoperatively in Open Unilateral Total Knee Arthroplasty
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Baudax Bio
- 04 Jun 2021 Results published in the Pain Medicine
- 26 Apr 2021 Results published in the Baudax Bio Media Release
- 23 Apr 2020 Results presented in the Baudax Bio media release.